medigraphic.com
ISSN 0185-6014 (Impreso)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2008, Número 3

<< Anterior Siguiente >>

Rev Mex Patol Clin Med Lab 2008; 55 (3)


Marcadores de índice de filtración glomerular: Cistatina C

Barba EJR

Idioma: Español
Referencias bibliográficas: 57
Paginas: 149-156
Archivo PDF: 116.75 Kb.


RESUMEN

Las concentraciones séricas de creatinina son el marcador diagnóstico más utilizado para el avalúo clínico de la medición del índice de filtración glomerular (IFG); sin embargo, tienen una serie de factores no renales que influyen en su producción, por ejemplo: masa muscular e ingesta de proteínas, además de que existen diversas dificultades para su análisis. La medición sérica de cistatina C ha sido propuesta como un marcador simple, fiable y exacto del índice de filtración glomerular.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. National Kidney Foundation: K/DOQ. Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (2, suppl 1): S17-S31.

  2. Hogg RJ, Furth S, Lemley KV, Portman R, Scwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS. National Kidney Foundation‘s Kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: Evaluation, classification, and stratification. Pediatrics 2003; 111: 1416-1421.

  3. Pucci L, Triscornia S, Luchesi D, Fotino C, Pellegrini G, Pardini E, Miccoli R, Del Prato E, Penno G. Cystatin C and Estimates of renal function: Searching for a better measure of kidney function in diabetic patients. Clinical Chemistry 2007; 53(3): 480-488.

  4. Obrenovic R, Petrovi D, Majki-Singh N, Trbojevi J, Stojimirovi B. Influence of proteinuria on cystatin C serum concentration in patients with primary glomerulonephritis. Jugoslav Med Biohem 2006; 25: 21-25.

  5. Samark MJ, Levey AS. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 2000; 35 (4, suppl 1): S117-S131.

  6. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey. Am J Kidney Dis 2003: 41(1): 1-12.

  7. Maclsaac RJ, Tsalamandris C, Thomas MC, Premaratne E, Panagiotopoulos S, Smith TJ, Poont A, Jenkins MA, Ratnaike SI, Powers DA, Jerums G. The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes. Diabetic Medicine 2007; 24: 443-448.

  8. Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, Kusek JW, Beck GJ, Collins AJ, Levey AS, Sarnak MJ. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 2007; 147: 19-27.

  9. Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN, II). Ann Intern Med 2007; 147: 19-27.

  10. Herget-Rosenthal S, Bökenkamp A, Hofmann W. How to estimate GFR-serum creatinine, serum cystatin C or equations? Clinical Biochemistry 2007; 40: 153-161.

  11. Oddoze C, Morange S, Portugal H, Berland Y, Dussol B. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis 2001; 38(2): 310-316.

  12. Fried LF, Shlipak MG, Crump C, Blayer AJ, Gottdiner JS, Kronmal RA, Kuller LH, Newman AB. Renal Insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 2003; 41: 1364-1372.

  13. Le Bricon T, Thervet E, Benlakehal M, Bousquet B, Legendre C, Erlich D. Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clinical Chemistry 1999; 45(12): 2243-2249.

  14. Levey AS, Kai-Uwe E, Tsukamoto Y, Levin A, Coresh J, Rossert J, de Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: A position statement from kidney disease: Improving global outcomes (KDIGO). Kidney International 2005; 67: 2089-2100.

  15. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant 2006 21(7): 1855-1862.

  16. Brändström E, Grzegorczyk A, Jacobsson L, Friberg P, Lindahl A, Aurell M. GFR measurement with iohexol and Cr-EDTA. A comparison of the two favoured GFR markers in Europe. Nephrol Dial Transplant 1998; 13: 1176-1182.

  17. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 2002; 40(2): 221-226.

  18. Coll E, Botey A, Álvarez L, Poch E, Quintó L, Taurina A, Vera M, Piera C, Darnell A. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000; 36(1): 29-34.

  19. Preiss DJ, Godber IM, Lamb EJ, Dalton RN, Gunn IR. The influence of a cooked-meat meal on estimated glomerular filtration rate. Ann Clin Biochem 2007; 44: 35-42.

  20. Bökenkamp A, Özden N, Dieterich C, Schumann G, Erich JHH, Brodehl J. Cystatin C and creatinine after successful kidney transplantation in children. Clinical Nephrology 1999; 52(6): 371-376.

  21. Van Den Noortgate NJ, Janssens WH, Delanghe JR, Afschrift MB, Lameire NR. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old. J Am Geriatr Soc 2002; 50: 1278-1282.

  22. Filler G, Priem F, Lepage N, Sinha P, Vollmer I, Clark H, Keely E, Matzinger M, Akbari A, Althaus A, Jung K. b-trace protein, cystatin C, b2-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clinical Chemistry 2002; 48(5): 729-736.

  23. Editorial. Cystatin C measurement: improved detection of mild decrements in glomerular filtration rate versus creatinine-based estimates? Am J Kidney Dis 2000; 36 (1): 205-207.

  24. Thomassen SA, Johannesen IL, Erlendsen EJ, Abrahamsen J, Randers E. Serum cystatin C as a marker of the renal function in patients with spinal cord injury. Spinal Cord 2002; 40: 524-528.

  25. Jayagopal V, Keevil BG, Atkin SL, Jennings PE, Kilpatrick ES. Paradoxical changes in cystatin C and serum creatinine in patients with hypo-and hyperthyroidism. Clinical Chemistry 2003; 49: 680-681.

  26. Antognoni MT, Siepi D, Porciello F, Fruganti G. Use of serum cystatin C determination as a marker of renal function in the dog. Vet Res Com 2005; 29 (suppl 2): 265-267.

  27. Shlipak MG, Sarnak MJ, Katz R, Fried L, Seliger S, Newman A, Siscovick D, Catherine Stehman-Breen C. Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol 2005; 45: 268-271.

  28. Randers E, Krue S, Erlandsen EJ, Danielsen H, Hansen LG. Reference interval for serum cystatin C in children. Clinical Chemistry 1999; 45: 1856-1858.

  29. Hoek FJ, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level. Nephrol Dial Transplant 2007 (Advance Access published April 1, 2007).

  30. Tian S, Kusano E, Ohara T, Tabel K, Itoh Y, Hawai T, Asano Y. Cystatin C measurement and its practical use in patients with various renal diseases. Clinical Nephrology 1997; 48(2): 104-108.

  31. Hermida J, Romero R, Tutor JC. Serum cystatin C-immunoglobulin high-molecular-weight complexes in kidney liver transplant patients. Kidney International 2001; 60: 1561-1564.

  32. Berghout A, Wulkan RW, den Hollander JG. Cystatin C and the risk of death. N Engl J Med 2005; 353(8): 842-843.

  33. Nilsson-Ehle P, Grubb A. New markers for the determination of GFR: Iohexol clearance and cystatin C serum concentration. Kidney International 1994; 46 (suppl 47): S17-S19.

  34. Croda-Todd M, Juárez E, Pedro Hernández P, Flores G, Rivera G, Bocanegra-García V. Reference intervals for serum cystatin C in healthy Mexican adults. Clin Chem Lab Med 2007; 45(7): 925-927.

  35. Bökenkamp A, Domenetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C-A new marker of glomerular filtration rate in children independent of age and height. Pediatrics 1998; 101(5): 875-881.

  36. Chantrel F, Agin A, Offner M, Koehl C, Moulin B, Hannedouche T. Comparison of cystatin C versus creatinine for detection of mild renal failure. Clinical Nephrology 2000; 54(5): 374-381.

  37. Pöge U, Stoschus B, Stoffel-Wagner B, Gerhardt T, Klehr HU, Sauerbruch T, Woitas RP. Cystatin C as an endogenous marker of glomerular filtration rate in renal transplant patients. Kidney Blood Press 2003; 26: 55-60.

  38. Jernberg T, Lindahl B, James S, Larsson A, Lars-Olof H, Wallentin L. Cystatin C. A novel predictor of outcomes in suspected or confirmed Non-ST-elevation acute coronary syndrome. Circulation 2004; 110: 2342-2348.

  39. Villa P, Jiménez M, Cruz-Soriano M, Manzanares J, Casasnovas P. FERUM cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Critical Care 2005; 9 (2): R139-R143.

  40. Hermida J, Romero R, Tutor JC. Relationship between serum cystatin C and creatinine in kidney and liver transplant patients. Clinica Chimica Acta 2002; 316: 165-170.

  41. K¡Herget-Rosenthal S, Marggraf G, Hüsing J, Göring F, Pietruck F, Janssen O, Philipp T, Kribben A. Early detection of acute renal failure by serum cystatin C. Kidney International 2004; 66: 1115-1122.

  42. Berenguer-Pina JJ, Noguera J, Cañizares F, Hernández-Bernal C, Velasco-Conesa E, Lozano-Postigo C, Patiña A, Cabezuelo J, Acosta F, Martínez-Hernández P, Ramírez P, Parrilla P. Cystatin C: A marker of glomerular filtration rate in liver transplantation. Transplant Proc 2002; 34: 268-269.

  43. Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma Concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate. Clinical Chemistry 2005; 51: 1-7.

  44. Leach TD, KitiyakarA C, Price CP, Stevens JM, Newman DJ. Prognostic significance of serum cystatin C concentrations in renal transplant recipients: 5-year follow-up. Transplant Proc 2002: 34: 1152-1158.

  45. Samyn M, Cheeseman P, Bevis L, Taylor R, Samaroo B, Buxton-Thomas M, Heaton N, Rela M, Mieli-Vergani G, Dhawan A. Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transplantation 2005; 11(3): 344-349.

  46. Simonsen OGA, Sturfelt G, Truedsson L, Thysell H. Serum concentration of cystatin C, factor D and b2-microglobulin as a measure of glomerular filtration rate. Acte Med Scand 1985; 218: 499-503.

  47. Plebani M, Mussap M, Bertelli L, Moggi G, Ruzzante N, Fanos V, Cataldi L. Determinazione della cistatina C sierica in gestanti al momento del parto e nei loro neonati. Pediatr Med Chir 1997; 19: 325-329.

  48. Löfberg H, Grubb AO. Quantitation of g-trace in human biological fluids: indications for production in the central nervous system. Scand J Clin Lab Invest 1979; 39: 619-626.

  49. Pergande M, Jung K. Sandwich enzyme immunoassay of cystatin C in serum with commercially available antibodies. Clin Chem 1993; 39: 1885-1890.

  50. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb A, Price CP. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312-318.

  51. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921-1926.

  52. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney International 1995; 47: 312-318.

  53. Deinum J, Frans HM. Cystatin for estimation of glomerular filtration rate? Lancet 2000; 356: 1624-1625.

  54. Lamb EJ, O’Riordan SE, Webb MC, Newman DJ. Serum cystatin C may be a better marker of renal impairment than creatinine. J Am Geriat Soc 2003; 51(11): 1674.

  55. Gantzer ML. Cystatin C: Analysis and utility in monitoring GFR. Laboratory Medicine 2003; 34(2): 118-123.

  56. Fliser D, Ritz E. Serum Cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001; 37(1): 79-83.

  57. Randers E, Erlandsen EJ, Pedersen OL, Hasling C, Danielsen H. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clinical Nephrology 2000; 54(3): 203-209.




2020     |     www.medigraphic.com